Biological E Reveals Results of Phase II/III Trials on JE Vaccine

Hyderabad based Biological E Limited has revealed that it has completed the Phase II and III trials of its inactivated Japanese Encephalitis (JE) vaccine on healthy kids aged between 1 to 3 years of age.

The trials were conducted in eight different sites across the country and the company revealed that it will be submitted the results of the study to the Indian regulatory authority for licensure.

What You Should Know about Japanese Encephalitis - Types, Causes, Symptoms, Diagnosis & Treatment
Japanese encephalitis is a mosquito borne viral disease associated with inflammation of the brain.

Commenting on the results of these trials, Dr. Vijay Kumar Datla, Chairman and Managing Director of Biological E. Limited said, "We are excited about the successful completion of our phase-II/III clinical study which enables us to offer this novel and safe vaccine to combat Japanese Encephalitis not only in India but also across Asia.”

JE is one of the most common viral encephalitis that occurs in this part of the world. It is estimated that there are around 50,000 cases in Asia on an annual basis with resulting mortality rates ranging from 0.3% to 60%.

Source-Medindia

Head aches - Types - Symptoms - Migraine - Diagnosis - Treatment
A headache literally means ‘pain in the head’. It is a common complaint that may occur frequently in some

Reye’s Syndrome-Symptoms-Diagnosis-Treatment-Prognosis-Prevention
Reye's syndrome is a medical emergency chiefly affecting children and teenagers and is marked by the rapid development of life-threatening neurological symptoms.